Table 4 Clinical ranges:* follow-up hemodialysis and peritoneal dialysis patients, per Canada 2012

Dialysis Adequacy

N

11,380

1,759

Urea Reduction Ratio ≥65

%

86.7

-

Kt/V, ^† <1.2

%

23.4

8.7

Kt/V 1.2–2.0

%

52.1**

14.5

Kt/V >2.0

%

2.4

33.0

Test Not Done

%

22.2

43.8

Hemoglobin

N

14,584

3,106

<95 g/L

%

11.6

11.9

95–115 g/L

%

55.3**

54.1**

>115 g/L

%

32.8

33.2

Test Not Done

%

0.3

0.7

Transferrin Saturation

N

13,827

2,829

<20%

%

25.9

20.2

20%–50%

%

64.2**

66.0**

>50%

%

4.4

4.3

Test Not Done

%

5.5

9.6

Ferritin

N

13,831

2,870

<100 ng/mL

%

13.1

18.6

100–800 ng/mL

%

64.8**

63.9**

>800 ng/mL

%

16.6

9.2

Test Not Done

%

5.5

8.2

Target for Hgb, TSAT and FTN

%

26.3

27.1

Erythropoietin

%

89.1

73.6

Use Iron Administration

No Iron

%

31.4

50.8

Oral

%

12.0

43.0

IV

%

53.4

4.6

Oral and IV

%

2.9

1.0

Unknown/Other

%

0.4

0.6

Calcium

N

13,936

2,966

<2.1 mmol/L

%

11.5

6.5

2.1–2.54 mmol/L

%

69.1**

67.6**

>2.54 mmol/L

%

14.7

20.8

Test Not Done

%

4.8

5.2

Phosphate

N

14,570

3,099

<0.80 mmol/L

%

1.9

0.5

0.80–1.45 mmol/L

%

36.8**

33.9**

>1.45 mmol/L

%

60.9

64.6

Test Not Done

%

0.4

0.9

Parathormone

N

14,268

2,965

<10.6 pmol/L

%

15.4

14.4

10.6–53.0 pmol/L

%

53.6**

58.2**

>53.0 pmol/L

%

28.6

22.3

Test Not Done

%

2.5

5.2

Target for Ca, P and PTH

%

16.3

16.6

Albumin

N

14,469

3,088

<35 g/L

%

38.3

53.8

35-40 g/L

%

44.3**

36.0**

>40 g/L

%

16.2**

8.9**

Test Not Done

%

1.1

1.3

HbA1c

N

7,055

1,586

≤7%

%

61.7

62.7

On Kidney Transplant Wait List

%

21.7

34.9

5+ Treatments/Week

%

4.4

-

15+ Hours/Week

%

8.6

-